Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Kangxin Wang
Observed name:
Kang-Xin Wang
Institutions:
Jiangsu Health Vocational College,
Southeast University,
Xi'an Jiaotong University
Observed institutions:
Jiangsu University,
Xiamen University,
Nanjing Drum Tower Hospital,
Jiangsu Province Hospital,
Jiangsu Health Vocational College,
Xi’an Jiaotong-Liverpool University,
Southeast University,
Xi'an Jiaotong University,
Nanjing University
show all 9
ORCID:
0000-0001-7934-2633
Observed ORCID:
0000-0001-7934-2633
OpenAlex ID:
A5044352450
First-line camrelizumab (a PD-1 inhibitor) plus apatinib (an VEGFR-2 inhibitor) and chemotherapy for advanced gastric cancer (SPACE): a phase 1 study
2024
·
Xiaofeng Chen
, Hao Xu
, et al.
·
Signal Transduction and Targeted Therapy
·
52
PDF
Radiomic analysis using contrast-enhanced CT: predict treatment response to pulsed low dose rate radiotherapy in gastric carcinoma with abdominal cavity metastasis
2018
·
Zhen Hou
, Yang Yang
, et al.
·
Quantitative Imaging in Medicine and Surgery
·
49
PDF
Periostin deficiency reduces PD-1+ tumor-associated macrophage infiltration and enhances anti-PD-1 efficacy in colorectal cancer
2023
·
Tian Wei
, Kangxin Wang
, et al.
·
Cell Reports
·
43
Effects of the IGF-1/PTEN/Akt/FoxO signaling pathway on male reproduction in rats subjected to water immersion and restraint stress
2016
·
Pan Huang
, Zhengrong Zhou
, et al.
·
Molecular Medicine Reports
·
33
Current Progress and Future Perspectives of Immune Checkpoint Inhibitors in Biliary Tract Cancer
2021
·
Poshita-Kumari Seesaha
, Kang-Xin Wang
, et al.
·
OncoTargets and Therapy
·
10
PDF
Low-dose apatinib combined with camrelizumab and the SOX regimen in the neoadjuvant treatment of locally advanced gastric/gastroesophageal junction adenocarcinoma (SPACE-neo): a protocol for an open-label, single-arm, clinical trial
2022
·
Lanlan Pan
, Yitong Tian
, et al.
·
Journal of Gastrointestinal Oncology
·
6
PDF
Study on Efficacy and Safety of Low-Dose Apatinib Combined with Camrelizumab and SOX Regimen as First-Line Treatment of Locally Advanced and Unresectable Gastric/Gastroesophageal Junction Cancer: A Protocol for an Open-Label, Dose Escalation and Extension Phase Ib Clinical Trial
2021
·
Kang-Xin Wang
, Ting-Yun Cui
, et al.
·
OncoTargets and Therapy
·
6
PDF
Hepatic Arterial Infusion Oxaliplatin Plus Oral S-1 Chemotherapy in Gastric Cancer with Unresectable Liver Metastases: A Case Series and Literature Review
2020
·
Kangxin Wang
, Xuebin Zhang
, et al.
·
Cancer Management and Research
·
5
PDF
Putting student partnership and collaboration centre-stage in a research-led context: A case study of the Summer Undergraduate Research Fellowship programme at Xi’an Jiaotong-Liverpool University
2019
·
Henk Huijser
, James Wilson
, et al.
·
International Journal for Students as Partners
·
5
PDF
Comprehensive clinical and genetic characterization of hyperprogressive biliary tract cancer during PD-1 blockade monotherapy: case report and literature review
2025
·
Kang-Xin Wang
, Xu-Dong Yang
, et al.
·
BMC Medical Genomics
·
2
Clinical significance of serum tumor marker for advanced gastric cancer with palliative chemotherapy: A retrospective study.
2017
·
Yahui Zhu
, Baorui Liu
, et al.
·
Journal of Clinical Oncology
·
1
The effect of late-gestational anemia on maternal and neonatal outcomes in twin pregnancies: a retrospective cohort study
2025
·
Xiayang Li
, Yishuai Huang
, et al.
·
Annals of Medicine
PDF
Hepatic arterial infusion oxaliplatin plus oral S-1 chemotherapy to improve prognosis for gastric cancer with multiple liver metastases.
2020
·
Kangxin Wang
, Yang Yang
·
Journal of Clinical Oncology
Show more works
View as search
Works count:
13
Citation count:
212
H-index:
6
I10-index:
5
Year
Topic
Type